NOW LOADING

Has The Time Arrived To Buy This Stock-ONTO

Acrobull UK Advisory Services Ltd.

 

 

May 142025
NameTickerSector/IndustryMarket CapRisk Factor 

Onto Innovation Inc.

NYSE-ONTOTechnology$4.848 BillionMedium 
       

 

Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs optical metrology and inspection worldwide. The company offers lithography systems and process control analytical software.

 

 

 

Recent Highlights

 

 

  • CEO StatementWe are pleased to report another record quarter for Onto Innovation, underscoring our strong market alignment and operational improvements, which resulted in record cash generation of 35% of revenue. 

 

  • The robust demand in advanced nodes is effectively demonstrating the strength of our optical metrology portfolio, while the packaging market is growing and evolving to require the need for more advanced 2D and 3D inspection and metrology solutions. Our product roadmaps are well aligned with these technology transitions expected late this year and early 2026.
First Quarter 2025 Highlights

 

 

 

  • Revenue- Onto Innovation reported a 16.5% growth in total revenue in Q1 2025, to $266.61 million, up from $228.85 million in Q1 2024. The Systems and Software segment made a considerable contribution, totaling $231.15 million. Meanwhile, the Parts segment added $18.18 million, and Services brought in $17.28 million, resulting in a solid overall revenue total. 

 

  • EPS- Onto Innovation's earnings per share (EPS) climbed by 36.8% to $1.30 in 2025 Q1, up from $0.95 in 2024 Q1, indicating continued earnings growth. 

 

  • Net Income- The company's profitability improved, with a net income of $64.09 million, up 36.8% from $46.85 million the previous year. This quarter marked the highest fiscal Q1 net profits in more than two decades. The EPS numbers show strong performance.

 

Stock Observation- The company has reported good financial results in the first quarter however the company overall fundamentals remain strong hence positive results are expected in the next quarter. The RSI level for the stock is at 42 showing oversold conditions. 

 

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

 

 

 

 
Considering all the factors and financials of the company Acrobull UK maintains Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull UK only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull UK would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull UK is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull UK does not guarantee returns. 

 

Acrobull UK Recommendation Based on Evaluation

 

Current Market Price$99.19 USD
Acrobull RecommendationBuy at $97.15 USD
Target Price$110.25 USD
RSI Level14 Day RSI 42
Total Shares Outstanding48.87 Million

Shares held by Insiders

Risk Factor

Stop Loss

0.65%

Medium

5%

 

 

Acro Bull UK Logo

© Copyright Acro Bull UK All Rights Reserved 2025

Accepted Payment Modes